March 17, 2020 / 12:53 PM / 18 days ago

BRIEF-Cortexyme Reports Q4 Loss Per Share Of $0.46

March 17 (Reuters) - Cortexyme Inc:

* CORTEXYME ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

* Q4 LOSS PER SHARE $0.46

* Q4 EARNINGS PER SHARE ESTIMATE $-0.40 — REFINITIV IBES DATA

* CORTEXYME - CASH, CASH EQUIVALENTS, & SHORT AND LONG-TERM MARKETABLE SECURITIES AS OF DEC 31, 2019, WERE $116.6 MILLION

* CORTEXYME - IS NOW SCREENING ITS PROPRIETARY LIBRARY OF SMALL MOLECULES FOR A POSSIBLE TREATMENT FOR CORONAVIRUSES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below